Sheaff Brock Investment Advisors, LLC Neurocrine Biosciences Inc Transaction History
Sheaff Brock Investment Advisors, LLC
- $1.14 Billion
- Q4 2024
A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 2,499 shares of NBIX stock, worth $289,634. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,499
Previous 2,238
11.66%
Holding current value
$289,634
Previous $257,000
32.68%
% of portfolio
0.03%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
654Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.64 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$567 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$350 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$294 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...